⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9845878 | 0.97 | FAAH (0.44) | — | |
| SCHEMBL2371310 | 0.88 | — | — | |
| SCHEMBL1643614 | 0.85 | — | — | |
| SCHEMBL28506793 | 0.82 | FAAH (0.36) | — | |
| SCHEMBL28508833 | 0.82 | FAAH (0.36) | — | |
| SCHEMBL5179153 | 0.77 | — | — | |
| SCHEMBL9784243 | 0.75 | — | — | |
| SCHEMBL844037 | 0.74 | — | — | |
| SCHEMBL5178461 | 0.74 | — | — | |
| SCHEMBL800964 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108409778-A | The preparation method and applications of high refractive index modified silane | 深圳市安品有机硅材料有限公司 | 2018-08-17 | — | — | CN | claimed |
| EP-0746551-B1 | OPTICALLY PURE 4-ARYL-2-HYDROXYTETRONIC ACIDS | UNIV OHIO STATE RES FOUND (US) | 2002-09-04 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-4720077-A1 | ORGANOMETALLIC TIN OXO CARBOXYLATE CLUSTERS WITH MIXED ORGANIC LIGANDS FOR EUV LITHOGRAPHY | Merck Patent GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025047358-A1 | ELECTROLYTIC CAPACITOR AND ADDITIVE FOR LIQUID COMPONENT OF ELECTROLYTIC CAPACITOR | パナソニックＩＰマネジメント株式会社 | 2025-03-06 | — | — | WO | disclosed |
| WO-2025032169-A1 | POSITIVE TONE PATTERNS FROM METAL ORGANIC RESISTS | MERCK PATENT GMBH (DE) | 2025-02-13 | — | — | WO | disclosed |
| WO-2025032041-A1 | ORGANOMETALLIC CLUSTER CONTAINING SULFUR FOR EUV LITHOGRAPHY BACKGROUND | MERCK PATENT GMBH (DE) | 2025-02-13 | — | — | WO | disclosed |
| WO-2024246119-A1 | ORGANOMETALLIC TIN OXO CARBOXYLATE CLUSTERS WITH MIXED ORGANIC LIGANDS FOR EUV LITHOGRAPHY | MERCK PATENT GMBH (DE) | 2024-12-05 | — | — | WO | disclosed |
| US-20240287015-A1 | Method for Producing an Ionizable Lipid | NANOVATION THERAPEUTICS INC. (CA) | 2024-08-29 | — | — | US | disclosed |
| WO-2022246555-A1 | METHOD FOR PRODUCING AN IONIZABLE LIPID | NANOVATION THERAPEUTICS INC. (CA) | 2022-12-01 | — | — | WO | disclosed |
| US-11129784-B2 | Shaping keratin fibres using oxoethanoic acid and/or derivatives thereof | THE PROCTER AND GAMBLE COMPANY (US) | 2021-09-28 | — | — | US | disclosed |
| EP-0445467-A1 | Renin inhibitors and antiviral agents | Beecham Group p.l.c. (GB) | 1991-09-11 | — | — | EP | disclosed |
| CN-1051912-A | Improved gangliosides and functional derivatives thereof | FIDIA B P A (IT) | 1991-06-05 | — | — | CN | disclosed |
| WO-1991004027-A1 | NEW N-ARYL AND N-HETEROARYLAMIDE AND UREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A: CHOLESTEROL ACYL TRANSFERASE (ACAT) | PFIZER INC. (US) | 1991-04-04 | — | — | WO | disclosed |
| EP-0418071-A2 | New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase | PFIZER INC. (US) | 1991-03-20 | — | — | EP | disclosed |
| US-4428940-A | INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME | BEECHAM GROUP P.L.C. (GB) | 1984-01-31 | — | — | US | disclosed |
| EP-0060668-A1 | N-carboxyalkyl dipeptide derivatives and pharmaceutical compositions thereof | BEECHAM GROUP PLC (GB) | 1982-09-22 | — | — | EP | disclosed |
| US-4225589-A | ANTITUMOR | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | disclosed |
| US-3947469-A | PROSTAGLANDIN INTERMEDIATES | RECHERCHE ET INDUSTRIE THERAPEUTIQUES (R.I.T.) (BE) | 1976-03-30 | — | — | US | disclosed |